Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
12/13/2005 | US6974806 Preventing or treating acute myocardial infarction, unstable angina and peripheral artery occlusion |
12/13/2005 | CA2234066C Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
12/08/2005 | WO2005117242A1 Method and installation means for installing an electrical machine |
12/08/2005 | WO2005116015A1 Chromanol derivatives, method for the production thereof, and use thereof as an anti-inflammatory drug |
12/08/2005 | WO2005116012A1 Pyrrolidine derivative |
12/08/2005 | WO2005116009A1 Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors |
12/08/2005 | WO2005115992A1 Theramutein modulators |
12/08/2005 | WO2005115990A1 Cinnamide compound |
12/08/2005 | WO2005115987A1 Therapeutic compounds: pyridine n oxide scaffold |
12/08/2005 | WO2005115986A1 Therapeutic compounds: pyridine as scaffold |
12/08/2005 | WO2005115981A2 A process for the preparation of 1-(9h-carbazol-4-yloxy)-3-2-(-methoxyphenoxy)-ethyl amino-propan-2-ol |
12/08/2005 | WO2005115977A1 Pyrrolidine derivatives as cb1-receptor antagonists |
12/08/2005 | WO2005115976A1 3-amino-2-phenylpyrrolidine derivatives |
12/08/2005 | WO2005115975A1 Arylalkylamines and process for production thereof |
12/08/2005 | WO2005115384A2 Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation |
12/08/2005 | WO2005115145A2 Quinone substituted quinazoline and quinoline kinase inhibitors |
12/08/2005 | WO2005077932A3 Chemokine receptor antagonists |
12/08/2005 | WO2005075436A3 Novel inhibitors of glutaminyl cyclase |
12/08/2005 | WO2005034940A3 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological, inflammatory, neuronal and other diseases |
12/08/2005 | WO2004096134A3 Substituted 1,4-diazepines and uses thereof |
12/08/2005 | US20050272931 Vanilloid receptor ligands and their use in treatments |
12/08/2005 | US20050272803 Phosphodiesterase 4 inhibitors |
12/08/2005 | US20050272798 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents |
12/08/2005 | US20050272794 Pyrazole derivatives, compositions containing such compounds and methods of use |
12/08/2005 | US20050272793 Pyrazole compounds and uses related thereto |
12/08/2005 | US20050272791 Lung melanoma metastasis, rheumatoid arthritis, 1-isopropylsulfonyl-2-amino-6-(2-(2,6-difluorophenyl)-5-(phenyl)-imidazol-4-yl)-benzimidazole |
12/08/2005 | US20050272789 Triazole-derived kinase inhibitors and uses thereof |
12/08/2005 | US20050272785 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials |
12/08/2005 | US20050272780 Small molecule inhibitors of rotamase enzyme activity |
12/08/2005 | US20050272777 Vanilloid receptor ligands and their use in treatments |
12/08/2005 | US20050272753 signal transducer and activator of transcription-6 inhibitors; asthma, COPD, respiratory, inflammatory and allergic diseases; compounds have less suppressive effect on immunological functions; 4-[(2,5 -difluorobenzyl) amino]-2-[(4-morpholin-4-ylphenyl)amino]pyrimidine-5 -carboxamide |
12/08/2005 | US20050272736 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
12/08/2005 | US20050272727 As antitumor and anticancer agents |
12/08/2005 | US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death |
12/08/2005 | US20050272699 1- and 2-substituted with carbo- or heterocyclic groups, e.g., 3-[4-(5-Difluoromethoxy-3-trifluoromethyl-pyrazol-1-yl)-phenyl]-2-(2-fluoro-phenyl)-acrylonitrile; inhibit the production of IL-2. |
12/08/2005 | US20050272675 Methods for isolating crystalline form I of 5-azacytidine |
12/08/2005 | US20050272036 Ketones |
12/08/2005 | US20050271592 Optical diagnostic and therapeutic agents and compositions |
12/08/2005 | DE3745196B4 1,2,4-Benzotriazine oxide derivs. - used for radio-sensitising hypoxic tumour cells and selectively killing hypoxic tumour cells |
12/08/2005 | CA2568046A1 3-amino-2-phenylpyrrolidine derivatives |
12/08/2005 | CA2567813A1 Theramutein modulators |
12/08/2005 | CA2566094A1 Cinnamide compound |
12/08/2005 | CA2565065A1 Therapeutic compounds: pyridine as scaffold |
12/08/2005 | CA2564668A1 Pyrrolidine derivatives |
12/07/2005 | EP1602655A1 Benzofuran derivative |
12/07/2005 | EP1601670A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
12/07/2005 | EP1601669A1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
12/07/2005 | EP1601664A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders |
12/07/2005 | EP1601659A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands |
12/07/2005 | EP1601657A1 Pyrazole modulators of atp-binding cassette transporters |
12/07/2005 | EP1601654A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides |
12/07/2005 | EP1601653A1 Process for the production of substituted nicotinic acid esters |
12/07/2005 | EP1601357A1 Heterocyclic kinase inhibitors: methods of use and synthesis |
12/07/2005 | EP1527053B1 Process for preparing rizatriptan |
12/07/2005 | EP1399438B1 Novel heteroaryl derivatives, their preparation and use |
12/07/2005 | EP1370258B1 Peptide deformylase inhibitors |
12/07/2005 | EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
12/07/2005 | EP1175410B1 Pesticidal triazine derivatives |
12/07/2005 | EP1097138B1 Pharmaceutical compositions comprising 2-quinolones |
12/07/2005 | EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
12/07/2005 | EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
12/07/2005 | CN1705659A Large conductance calcium-activated k channel opener |
12/07/2005 | CN1705658A Process for making spirolactone compounds |
12/07/2005 | CN1705653A 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
12/07/2005 | CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
12/07/2005 | CN1705647A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
12/07/2005 | CN1704406A Intermediate for the preparation of epimino |
12/07/2005 | CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor |
12/07/2005 | CN1230432C Substituted phenyl-Piperazine derivatives, their preparation and use |
12/07/2005 | CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors |
12/07/2005 | CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives |
12/07/2005 | CN1230421C Amide compounds and medicinal use thereof |
12/07/2005 | CN1230416C Pharmaceutical compounds |
12/07/2005 | CN1230163C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens |
12/06/2005 | US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
12/06/2005 | US6972293 Diagnosis and treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, depression, overdose with benzodiazepine drugs, and enhancement of memory and alertness; gamma-aminobutyric acid (gaba) |
12/06/2005 | US6972290 Piperazine derivatives and their use as anti-inflammatory agents |
12/06/2005 | US6972288 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases |
12/06/2005 | CA2173257C Novel (r)-5-carbamoyl-8-fluoro-3-n,n-disubstituted-amino-3,4-dihydro-2h-1-benzopyranes |
12/04/2005 | CA2568914A1 Therapeutic agents, and methods of making and using the same |
12/01/2005 | WO2005114331A1 Resist compound and resist composition |
12/01/2005 | WO2005113547A1 Ionic-liquid-supporting crown compound |
12/01/2005 | WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase |
12/01/2005 | WO2005113537A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
12/01/2005 | WO2005113536A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands |
12/01/2005 | WO2005113535A2 Pyrazinylmethyl lactam derivatives |
12/01/2005 | WO2005113531A1 Light-emitting device material and light-emitting device |
12/01/2005 | WO2005113527A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists |
12/01/2005 | WO2005113514A2 Substituted pyrimidines as inhibitors of bacterial type iii protein secretion systems |
12/01/2005 | WO2005113513A2 Aryl sulfonamides |
12/01/2005 | WO2005113511A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
12/01/2005 | WO2005113509A1 Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor |
12/01/2005 | WO2005113501A1 Neurogenic pain control agent composition |
12/01/2005 | WO2005113494A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
12/01/2005 | WO2005112932A2 Raf modulators and methods of use |
12/01/2005 | WO2005112925A1 Aryl sulfonamides |
12/01/2005 | WO2005112923A2 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes |
12/01/2005 | WO2005112630A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof |
12/01/2005 | WO2005100285A3 Novel alkyne compounds exhibiting an mch antagonistic effect and drugs containing said compounds |
12/01/2005 | WO2005095345A3 Heteroaryl guanidines as inhibitors of viral replication |